Literature DB >> 2466589

Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

M A Spiteri1, S W Clarke, L W Poulter.   

Abstract

Bronchoalveolar lavage (BAL) was performed on 10 patients with sarcoidosis and 10 normal volunteers. In each case aliquots of the lavage were used to prepare cytospins on which differential cell counts were performed. Immunocytological methods using monoclonal antibodies RFD1 and RFD7 (identifying dendritic cells and mature macrophages in normal tissues) were performed to identify macrophage subsets. Sarcoid BAL contained a significantly higher proportion of RFD1+ cells (mean 44.7 +/- 10.32% compared to 12.3 +/- 4.0% in normals). Much of this increase was accounted for by a highly significant rise in the proportion of cells with the double phenotype RFD1+/RFD7+ (27.2 +/- 6.1% in sarcoid compared to 7.3 +/- 2.0% in normal). Suspensions of sarcoid and normal BAL were also studied in autologous mixed lymphocyte reactions (AMLR) using peripheral blood mononuclear cells (PBM) as a responder population. AMLRs were therefore set up using BAL, PBM, and BAL with PBM. In each case reactivity was compared to mitomycin treated controls. These studies revealed that sarcoid PBM expressed markedly reduced AMLR reactivity when compared to normal but both sarcoid and normal BAL were relatively unreactive. BAL admixed with PBM suppressed peripheral blood AMLR reactivity in the normals. In sarcoid patients BAL admixed with PBM abolished AMLR completely. We suggest that changes within the BAL macrophage populations in sarcoid patients may significantly influence the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466589      PMCID: PMC1542020     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract.

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-26       Impact factor: 91.245

Review 2.  Pathogenesis of the granulomatous lung diseases.

Authors:  G W Hunninghake; K C Garrett; H B Richerson; J C Fantone; P A Ward; S I Rennard; P B Bitterman; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-09

3.  Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages.

Authors:  L W Poulter; G A Rook; J Steele; A Condez
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

4.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

5.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

6.  Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

Authors:  A Venet; A J Hance; C Saltini; B W Robinson; R G Crystal
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

7.  Heterogeneity of macrophage populations in human lymphoid tissue and peripheral blood.

Authors:  F M Hofman; D Lopez; L Husmann; P R Meyer; C R Taylor
Journal:  Cell Immunol       Date:  1984-10-01       Impact factor: 4.868

8.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.

Authors:  G W Hunninghake; J E Gadek; H M Fales; R G Crystal
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.

Authors:  A J Hance; S Douches; R J Winchester; V J Ferrans; R G Crystal
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  13 in total

1.  Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants.

Authors:  N Al-Saffar; P A Revell; A Kobayashi
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

2.  Inhaled corticosteroids in pulmonary sarcoidosis.

Authors:  M A Spiteri
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

3.  Characterization of immune inducer and suppressor macrophages from the normal human lung.

Authors:  M A Spiteri; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis.

Authors:  M A Spiteri; M Johnson; O Epstein; S Sherlock; S W Clarke; L W Poulter
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 5.  Dendritic Cell Trafficking and Function in Rare Lung Diseases.

Authors:  Huan Liu; Claudia Jakubzick; Andrew R Osterburg; Rebecca L Nelson; Nishant Gupta; Francis X McCormack; Michael T Borchers
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

6.  Expression of various MHC class II molecules and of intracellular adhesion molecule-1 (ICAM-1) on focal clusters of dendritic cells in iodine deficiency goitres.

Authors:  P Dimal; M Wilders-Truschnig; P Mooij; G Leb; O Eber; W Langsteger; J Hebenstreit; A Beham; C Stiegler; G Dohr
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

7.  Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease.

Authors:  M C Lipman; M A Johnson; D H Bray; L H Poulter
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 8.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

9.  Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease.

Authors:  M C Allison; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

10.  Alveolar macrophages from patients with bronchogenic carcinoma and sarcoidosis similarly express monocyte antigens.

Authors:  I L Barbosa; V A Gant; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.